NVTA

Invitae (NVTA)

Invitae Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:NVTA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/06	22 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2024/02/07	07 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2024/01/30	21 : 00	PR Newswire (US)	Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics	NYSE:NVTA	Invitae Corporation
2024/01/30	06 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:NVTA	Invitae Corporation
2024/01/25	06 : 34	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:NVTA	Invitae Corporation
2024/01/22	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2024/01/22	21 : 00	PR Newswire (US)	Invitae Completes Sale of Reproductive Health Assets to Natera	NYSE:NVTA	Invitae Corporation
2024/01/19	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/12/22	11 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/12/22	11 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/12/15	06 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/12/14	06 : 07	PR Newswire (US)	Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts	NYSE:NVTA	Invitae Corporation
2023/12/12	06 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/18	06 : 48	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/16	06 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/15	09 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/11/15	09 : 55	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/11/09	06 : 36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NVTA	Invitae Corporation
2023/11/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/09	06 : 01	PR Newswire (US)	Invitae Reports Third Quarter 2023 Financial Results	NYSE:NVTA	Invitae Corporation
2023/11/07	06 : 00	PR Newswire (US)	Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships	NYSE:NVTA	Invitae Corporation
2023/11/01	19 : 59	PR Newswire (US)	Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	NYSE:NVTA	Invitae Corporation
2023/10/26	00 : 00	PR Newswire (US)	Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results	NYSE:NVTA	Invitae Corporation
2023/10/21	07 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/10/20	05 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/10/20	05 : 30	PR Newswire (US)	Invitae Appoints Dr. David Sholehvar as Chief Operating Officer	NYSE:NVTA	Invitae Corporation
2023/10/13	05 : 15	PR Newswire (US)	Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer	NYSE:NVTA	Invitae Corporation
2023/10/11	05 : 30	PR Newswire (US)	Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics	NYSE:NVTA	Invitae Corporation
2023/10/04	01 : 07	PR Newswire (US)	Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization	NYSE:NVTA	Invitae Corporation
2023/10/03	10 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation